Human Hepatic Cell Cultures: In Vitro and In Vivo Drug Metabolism
暂无分享,去创建一个
X. Ponsoda | J. Castell | María José Gómez-Lechón | Teresa Donato | Xavier Ponsoda | José V Castell | T. Donato | M. Gómez‐Lechón
[1] X. Ponsoda,et al. Comparative metabolism of the nonsteroidal antiinflammatory drug, aceclofenac, in the rat, monkey, and human. , 1996, Drug metabolism and disposition: the biological fate of chemicals.
[2] C. Ioannides,et al. Cytochromes P450 and species differences in xenobiotic metabolism and activation of carcinogen. , 1998, Environmental health perspectives.
[3] X. Ponsoda,et al. Metabolism of aceclofenac in humans. , 1996, Drug metabolism and disposition: the biological fate of chemicals.
[4] C. Rodríguez-Antona,et al. Quantitative RT-PCR measurement of human cytochrome P-450s: application to drug induction studies. , 2000, Archives of biochemistry and biophysics.
[5] R. Ulrich,et al. Cultured hepatocytes as investigational models for hepatic toxicity: practical applications in drug discovery and development. , 1995, Toxicology letters.
[6] A. Seidel,et al. Cytochrome P450 mediated reactions studied in genetically engineered V79 Chinese hamster cells. , 1995, Pharmacogenetics.
[7] J. Castell,et al. Cytochrome P450 regulation by hepatocyte nuclear factor 4 in human hepatocytes: A study using adenovirus‐mediated antisense targeting , 2001, Hepatology.
[8] M. Gómez-Lechón,et al. 6 – Isolation, Culture and Use of Human Hepatocytes in Drug Research , 1997 .
[9] C. Guguen-Guillouzo,et al. Expression and induction of a large set of drug-metabolizing enzymes by the highly differentiated human hepatoma cell line BC2. , 2001, European journal of biochemistry.
[10] U. Meyer,et al. Molecular mechanisms of genetic polymorphisms of drug metabolism. , 1997, Annual review of pharmacology and toxicology.
[11] M. T. Donato,et al. Effect of xenobiotics on monooxygenase activities in cultured human hepatocytes. , 1990, Biochemical pharmacology.
[12] A. Li,et al. Preclinical evaluation of drug-drug interaction potential: present status of the application of primary human hepatocytes in the evaluation of cytochrome P450 induction. , 1997, Chemico-biological interactions.
[13] M. T. Donato,et al. Characterization of drug metabolizing activities in pig hepatocytes for use in bioartificial liver devices: comparison with other hepatic cellular models. , 1999, Journal of hepatology.
[14] J. Castell,et al. Re‐expression of C/EBPα induces CYP2B6, CYP2C9 and CYP2D6 genes in HepG2 cells , 1998 .
[15] Rodrigues Ad,et al. Integrated Cytochrome P450 Reaction Phenotyping: Attempting to Bridge the Gap Between cDNA-expressed Cytochromes P450 and Native Human Liver Microsomes , 1999 .
[16] R. Edwards,et al. Cytochrome P450 expression in human hepatocytes and hepatoma cell lines: molecular mechanisms that determine lower expression in cultured cells , 2002, Xenobiotica; the fate of foreign compounds in biological systems.
[17] X. Ponsoda,et al. Drug biotransformation by human hepatocytes. In vitro/in vivo metabolism by cells from the same donor. , 2001, Journal of hepatology.
[18] A. Pfeifer,et al. 18 – Drug Metabolism and Carcinogen Activation Studies with Human Genetically Engineered Cells , 1996 .
[19] M. Ranis,et al. Induction of Human Drug-Metabolizing Enzymes: Mechanisms and Implications , 1999 .
[20] I. Gut,et al. P450 in the rat and man: methods of investigation, substrate specificities and relevance to cancer. , 1994, Xenobiotica; the fate of foreign compounds in biological systems.
[21] M. T. Donato,et al. Effect of model inducers on cytochrome P450 activities of human hepatocytes in primary culture. , 1995, Drug metabolism and disposition: the biological fate of chemicals.
[22] F. Gonzalez,et al. Molecular genetics of the P-450 superfamily. , 1990, Pharmacology & therapeutics.
[23] R. Langenbach,et al. Human cell lines, derived from AHH-1 TK+/- human lymphoblasts, genetically engineered for expression of cytochromes P450. , 1993, Toxicology.